Galfalvy H, Shea E, de Vegvar J, Pantazatos S, Huang Y, Burke A
Br J Psychiatry. 2023; 223(3):415-421.
PMID: 37395098
PMC: 10514224.
DOI: 10.1192/bjp.2023.13.
Bartlett E, Yttredahl A, Boldrini M, Tyrer A, Hill K, Ananth M
Eur Psychiatry. 2023; 66(1):e17.
PMID: 36691786
PMC: 9970152.
DOI: 10.1192/j.eurpsy.2023.4.
Melhem N, Zhong Y, Miller J, Zanderigo F, Ogden R, Sublette M
Int J Neuropsychopharmacol. 2021; 25(1):36-45.
PMID: 34555145
PMC: 8756092.
DOI: 10.1093/ijnp/pyab060.
Locatelli I, Trachsel B, Rousson V
PLoS One. 2021; 16(3):e0248731.
PMID: 33730041
PMC: 7968714.
DOI: 10.1371/journal.pone.0248731.
Pillai R, Bartlett E, Ananth M, Zhu C, Yang J, Hajcak G
Neuroimage. 2020; 213:116733.
PMID: 32169543
PMC: 7254571.
DOI: 10.1016/j.neuroimage.2020.116733.
Prediction of lithium treatment response in bipolar depression using 5-HTT and 5-HT PET.
Ananth M, Bartlett E, DeLorenzo C, Lin X, Kunkel L, Vadhan N
Eur J Nucl Med Mol Imaging. 2020; 47(10):2417-2428.
PMID: 32055965
PMC: 8789023.
DOI: 10.1007/s00259-020-04681-6.
Cortisol Stress Response and in Vivo PET Imaging of Human Brain Serotonin 1A Receptor Binding.
Steinberg L, Rubin-Falcone H, Galfalvy H, Kaufman J, Miller J, Sublette M
Int J Neuropsychopharmacol. 2019; 22(5):329-338.
PMID: 30927011
PMC: 6499240.
DOI: 10.1093/ijnp/pyz009.
Kappa opioid receptor binding in major depression: A pilot study.
Miller J, Zanderigo F, Purushothaman P, DeLorenzo C, Rubin-Falcone H, Ogden R
Synapse. 2018; 72(9):e22042.
PMID: 29935119
PMC: 7599086.
DOI: 10.1002/syn.22042.
Higher 5-HT autoreceptor binding as an endophenotype for major depressive disorder identified in high risk offspring - A pilot study.
Milak M, Pantazatos S, Rashid R, Zanderigo F, DeLorenzo C, Hesselgrave N
Psychiatry Res Neuroimaging. 2018; 276:15-23.
PMID: 29702461
PMC: 5959803.
DOI: 10.1016/j.pscychresns.2018.04.002.
Molecular connectivity disruptions in males with major depressive disorder.
Pillai R, Zhang M, Yang J, Mann J, Oquendo M, Parsey R
J Cereb Blood Flow Metab. 2018; 39(8):1623-1634.
PMID: 29519187
PMC: 6681531.
DOI: 10.1177/0271678X18764053.
[C]Harmine Binding to Brain Monoamine Oxidase A: Test-Retest Properties and Noninvasive Quantification.
Zanderigo F, DAgostino A, Joshi N, Schain M, Kumar D, Parsey R
Mol Imaging Biol. 2018; 20(4):667-681.
PMID: 29423903
DOI: 10.1007/s11307-018-1165-3.
Will imaging individual raphe nuclei in males with major depressive disorder enhance diagnostic sensitivity and specificity?.
Pillai R, Zhang M, Yang J, Boldrini M, Mann J, Oquendo M
Depress Anxiety. 2018; 35(5):411-420.
PMID: 29365217
PMC: 5934332.
DOI: 10.1002/da.22721.
Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.
Lan M, Ogden R, Kumar D, Stern Y, Parsey R, Pelton G
J Alzheimers Dis. 2017; 60(3):939-947.
PMID: 28984586
PMC: 5679746.
DOI: 10.3233/JAD-161284.
Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
Ananth M, DeLorenzo C, Yang J, Mann J, Parsey R
J Nucl Med. 2017; 59(4):665-670.
PMID: 28935838
PMC: 5932749.
DOI: 10.2967/jnumed.117.189654.
A positron emission tomography study of the serotonergic system in relation to anxiety in depression.
Iscan Z, Rakesh G, Rossano S, Yang J, Zhang M, Miller J
Eur Neuropsychopharmacol. 2017; 27(10):1011-1021.
PMID: 28811068
PMC: 5623123.
DOI: 10.1016/j.euroneuro.2017.07.009.
A hybrid deconvolution approach for estimation of in vivo non-displaceable binding for brain PET targets without a reference region.
Zanderigo F, Mann J, Ogden R
PLoS One. 2017; 12(5):e0176636.
PMID: 28459878
PMC: 5411064.
DOI: 10.1371/journal.pone.0176636.
Effects of common anesthetic agents on [F]flumazenil binding to the GABA receptor.
Palner M, Beinat C, Banister S, Zanderigo F, Park J, Shen B
EJNMMI Res. 2016; 6(1):80.
PMID: 27826950
PMC: 5101239.
DOI: 10.1186/s13550-016-0235-2.
Lack of association between the serotonin transporter and serotonin 1A receptor: an in vivo PET imaging study in healthy adults.
Strupp-Levitsky M, Miller J, Rubin-Falcone H, Zanderigo F, Milak M, Sullivan G
Psychiatry Res Neuroimaging. 2016; 255:81-6.
PMID: 27567324
PMC: 5175477.
DOI: 10.1016/j.pscychresns.2016.08.002.
Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior.
Oquendo M, Galfalvy H, Sullivan G, Miller J, Milak M, Sublette M
JAMA Psychiatry. 2016; 73(10):1048-1055.
PMID: 27463606
PMC: 6552665.
DOI: 10.1001/jamapsychiatry.2016.1478.
Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688.
DeLorenzo C, Sovago J, Gardus J, Xu J, Yang J, Behrje R
Transl Psychiatry. 2015; 5:e693.
PMID: 26645628
PMC: 5068588.
DOI: 10.1038/tp.2015.189.